Eiko Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 14.00 Cr
as on 10-06-2024
- Paid Up Capital ₹ 12.45 Cr
as on 10-06-2024
- Company Age 47 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.00 Cr
as on 10-06-2024
- Revenue -26.49%
(FY 2023)
- Profit 8.93%
(FY 2023)
- Ebitda -26.32%
(FY 2023)
- Net Worth 2.77%
(FY 2023)
- Total Assets -11.04%
(FY 2023)
About Eiko Lifesciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 540204.
The Corporate was formerly known as Ornate Ventures Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 14.00 Cr and a paid-up capital of Rs 12.45 Cr.
The company has closed loans amounting to ₹7.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Eiko Lifesciences Limited India are Chintan Doshi as COMPANY SECRETARY and Jaid Kojar as Cfo. Laxmikant Kabra, Bhavesh Tanna, Rajkumar Baheti, and Three other members serve as directors at the Company.
- CIN/LLPIN
L65993MH1977PLC258134
- Company No.
258134
- Stock Symbol
BSE : 540204
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Jan 1977
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Eiko Lifesciences Limited offer?
Eiko Lifesciences Limited offers a wide range of products and services, including ISO & Quality Management Consultants, Certification Services, Legal Advisors & Consultants, Legal Consultants.
Who are the key members and board of directors at Eiko Lifesciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chintan Doshi  | Company Secretary | Current | |
| Jaid Kojar | CFO | 09-Feb-2022 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajkumar Baheti | Director | 10-Feb-2021 | Current |
| Laxmikant Kabra | Director | 26-Aug-2013 | Current |
| Bhavesh Tanna | Director | 26-Aug-2013 | Current |
| Mandar Patil | Director | 17-Oct-2014 | Current |
| Kajal Kothari | Director | 09-Sep-2020 | Current |
| Umesh More | Whole-Time Director | 12-Nov-2020 | Current |
Financial Performance and Corporate Structure Insights of Eiko Lifesciences.
Eiko Lifesciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.49% decrease. The company also saw a slight improvement in profitability, with a 8.93% increase in profit. The company's net worth moved up by a moderate rise of 2.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eiko Lifesciences?
In 2022, Eiko Lifesciences had a promoter holding of 10.59% and a public holding of 89.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 May 2021 | ₹7.00 Cr | Satisfied |
How Many Employees Work at Eiko Lifesciences?
Unlock and access historical data on people associated with Eiko Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eiko Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eiko Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
